Rockwell Medical (RMTI) Income from Non-Controlling Interests (2019 - 2023)
Rockwell Medical (RMTI) posted Income from Non-Controlling Interests of -$18000.0 for Q2 2023, down 500.0% on a QoQ basis from -$3000.0 in Q1 2023.
Rockwell Medical (RMTI) Income from Non-Controlling Interests (2019 - 2023) Analysis & Trends
Rockwell Medical's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at -$18000.0 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 28.43 Mn | 4.54 Mn | 2.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -18,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -7,000.00 |
| Jun 30, 2020 | -6,000.00 |
| Mar 31, 2020 | -7,000.00 |
| Jun 30, 2019 | 12,000.00 |
| Mar 31, 2019 | -7,000.00 |